Dr. Nirmal Saran is a Arlington, Texas based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Nirmal Saran is E4933 for Ophthalmology in Texas. Dr. Nirmal Saran is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Nirmal Saran speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
2726 Matlock Rd, Ste A, Arlington, Texas, 76015-2528
Phone:
817-461-2893
Fax:
817-276-0271
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1104881531
NPI Enumeration Date:
19 Apr, 2006
NPI Last Update On:
25 Feb, 2008
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Nirmal Saran are as mentioned below.
License Number
Specialization
State
Status
E4933
Ophthalmology
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2726 Matlock Rd, Ste A Arlington, Texas
Zip:
76015
Phone Number:
817-461-2893
Fax Number:
817-276-0271
Patients can reach Dr. Nirmal Saran at 2726 Matlock Rd, Ste A, Arlington, Texas or can call to book an appointment on 817-461-2893. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.